| Zhao, Weifeng |
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A |
|
|
| Completed | 3 | 750 | RoW | ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273 | Guangdong Raynovent Biotech Co., Ltd | Influenza A | 04/23 | 05/23 | | |
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial. |
|
|
| Completed | 3 | 248 | RoW | Hydronidone capsules, F351, The placebo capsules, N | Beijing Continent Pharmaceutical Co, Ltd. | Liver Fibrosis | 10/24 | 10/24 | | |
NCT06485401: To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects |
|
|
| Recruiting | 1 | 32 | RoW | ADC189 | Jiaxing AnDiCon Biotech Co.,Ltd | Influenza Type A, Influenza Type B | 09/24 | 10/24 | | |
HRS-5965-103, NCT06674915: Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment |
|
|
| Recruiting | 1 | 28 | RoW | HRS-5965 capsules | Chengdu Suncadia Medicine Co., Ltd. | Complement Mediated Primary or Secondary Glomerular Diseases | 03/25 | 03/25 | | |
Paradise, NCT05671315: A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients |
|
|
| Recruiting | N/A | 267 | RoW | Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide analogue | Qing XIe | Chronic Hepatitis B, Intermediate to High Risk of HCC | 08/23 | 04/26 | | |
